SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-026050
Filing Date
2023-07-31
Accepted
2023-07-31 14:07:42
Documents
67
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1052615
2 ex31-1.htm EX-31.1 10321
3 ex32-1.htm EX-32.1 5539
  Complete submission text file 0001493152-23-026050.txt   6027191

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bixt-20230630.xsd EX-101.SCH 51736
5 XBRL CALCULATION FILE bixt-20230630_cal.xml EX-101.CAL 46646
6 XBRL DEFINITION FILE bixt-20230630_def.xml EX-101.DEF 216093
7 XBRL LABEL FILE bixt-20230630_lab.xml EX-101.LAB 378170
8 XBRL PRESENTATION FILE bixt-20230630_pre.xml EX-101.PRE 311289
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1037873
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 231126532
SIC: 2834 Pharmaceutical Preparations